We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

67 hedge funds and large institutions have $122M invested in TG Therapeutics in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 2

680% more call options, than puts

Call options by funds: $7.49M | Put options by funds: $960K

52% more capital invested

Capital invested by funds: $80.2M → $122M (+$41.7M)

32% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 19

31% more funds holding

Funds holding: 51 → 67 (+16)

Holders
67
Holders Change
+16
Holders Change %
+31.37%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
25
Reduced
19
Closed
2
Calls
$7.49M
Puts
$960K
Net Calls
+$6.53M
Net Calls Change
+$5.01M

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$4.03M
2
Millennium Management
Millennium Management
New York
+$1.73M
3
TC
TFS Capital
Pennsylvania
+$1.07M
4
CCI
Columbus Circle Investors
+$1.02M
5
Invesco
Invesco
Georgia
+$899K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$3.52M
2
SFM
Sphera Funds Management
Israel
-$895K
3
SGAM
Smith Group Asset Management
Texas
-$721K
4
Morgan Stanley
Morgan Stanley
New York
-$592K
5
Jennison Associates
Jennison Associates
New York
-$307K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$511K +$161K +25,120 +85%
Group One Trading
27
Group One Trading
Illinois
$465K +$90.8K +14,204 +40%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$434K +$122K +19,067 +70%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$402K +$64.6K +10,100 +31%
CS
30
Credit Suisse
Switzerland
$362K +$247K +38,566 New
Charles Schwab
31
Charles Schwab
California
$324K -$98.5K -15,400 -31%
TA
32
Teachers Advisors
New York
$309K +$74.7K +11,683 +55%
WMSA
33
Weiss Multi-Strategy Advisers
New York
$235K +$160K +25,000 New
SAM
34
Silphium Asset Management
United Kingdom
$188K +$128K +20,000 New
VOYA Investment Management
35
VOYA Investment Management
Georgia
$184K +$125K +19,552 New
MLICM
36
Metropolitan Life Insurance Company (MetLife)
New York
$183K +$124K +19,448 New
Morgan Stanley
37
Morgan Stanley
New York
$177K -$592K -92,574 -83%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$176K +$51.7K +8,088 +76%
NFA
39
Nationwide Fund Advisors
Ohio
$169K +$31.4K +4,918 +38%
Two Sigma Investments
40
Two Sigma Investments
New York
$167K +$114K +17,812 New
AQR Capital Management
41
AQR Capital Management
Connecticut
$164K -$164K -25,600 -59%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$145K +$99K +15,486 New
AIG
43
American International Group
New York
$144K +$30.6K +4,791 +45%
PAAMCP
44
Pacific Alternative Asset Management Company (PAAMCO)
California
$121K +$82.2K +12,850 New
ProShare Advisors
45
ProShare Advisors
Maryland
$107K -$27.5K -4,296 -27%
AllianceBernstein
46
AllianceBernstein
Tennessee
$105K +$71.1K +11,118 +13,559%
US Bancorp
47
US Bancorp
Minnesota
$101K +$68.9K +10,775 New
Goldman Sachs
48
Goldman Sachs
New York
$97K +$65.7K +10,282 New
BA
49
BlackRock Advisors
Delaware
$93K +$1.45K +227 +2%
BRWA
50
B. Riley Wealth Advisors
Florida
$82.8K -$28.9K -4,524 -34%
1
2
3

TGTX Hedge Fund Activity: Q2 2014 in Review

67 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q2 2014, worth a combined $122M — up 52% from $80.2M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TGTX positions and 2 closed out — a net gain of 16 holders — while 25 added to existing stakes and 19 trimmed.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $4.03M. The largest seller was JP Morgan Chase, cutting an estimated $3.52M.

  • 67 institutional investors held TG Therapeutics (TGTX) as of Q2 2014, up from 51 in Q1 2014.
  • Funds reported $122M of TG Therapeutics stock for Q2 2014, up 52% quarter-over-quarter.
  • 18 funds opened new TG Therapeutics positions in Q2 2014 and 2 closed out, a net change of +16 holders.
  • The largest TG Therapeutics buyer in Q2 2014 was Visium Asset Management, an estimated $4.03M added.
  • The largest TG Therapeutics seller in Q2 2014 was JP Morgan Chase, an estimated $3.52M sold.

Based on aggregated 13F filings for Q2 2014.